This article is more than 5 years old. Information may no longer be current.

Dexycu approval tops recent cataract surgery news

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Recent cataract surgery news has included an FDA approval and meeting news coverage.

Here are the top five most-read recent cataract surgery articles on Healio.com/OSN:

1. FDA approves Dexycu to treat cataract surgery inflammation

Icon Bioscience reported the FDA approved its new drug application for Dexycu, a dropless therapeutic designed to treat inflammation associated with cataract surgery. Read more.

2. Cataract, refractive error remain leading causes of global blindness

Cataract was the leading cause of blindness in people of all ages worldwide in 2015, according to a study. Read more.

3. ‘Postop is the new preop’ with the FDA approved light adjustable IOL

With adjustable IOL technology, patients can have whatever refractive outcome they prefer and Vance M. Thompson, MD, FACS, proposes that power adjustment of the implant will be preferred to power adjustment of the cornea. Read more.

4. Study shows advantages of femtosecond laser-assisted cataract surgery

Femtosecond laser-assisted cataract surgery with the Femto LDV Z8 laser from Ziemer offers the advantages of repeatable and precise outcomes, best placement of the capsulotomy and optimized surgical planning with the patient in one position from the beginning to end of surgery, according to a speaker at the European Society of Cataract and Refractive Surgeons winter meeting. Read more.

5. Understand patient expectations in residual refractive error with presbyopic IOLs

There are surgical and nonsurgical options for the management of patients who were implanted with a presbyopic IOL and have residual refractive error, according to Audrey Talley Rostov, MD. Read more.